Aortic Valve Replacement Market- By Product, By Procedure, By End User and By Geography Analysis - Forecast (2019 – 2025)

Key Takeaways

• In the coming years, growing interest in Aortic Valve Replacement is due to the rising prevalence of cardiovascular diseases among the general public.
• The product launch was a key sustainability strategy adopted by the market players to ensure the growth of Aortic Valve Replacement market.
• Europe region dominated the Aortic Valve Replacement Market during the forecast period.

Product - Segment Analysis

In 2018, Tissue/biological-based valve type dominated the Aortic Valve Replacement Market. Tissue based artificial heart valve are basically biological valves made from pig heart-valves or cow heart-sac tissue. In terms of Suture type, sutureless valves are projected to show a significant growth during the forecast period.

Procedure - Segment Analysis

In 2018, Minimally Invasive Surgery (MIS) segment dominated the Aortic Valve Replacement Market in terms of revenue. It is forecast to grow at a CAGR of 9.48% during the period under consideration. MIS surgery procedure is vastly opted as it limits the size and number of cuts or incisions, leading to less risks of infections.

End User - Segment Analysis

The Hospital segment dominated the Aortic Valve Replacement market in 2018. The dominance of hospital sector is due to the highly advanced medical technologies and equipment used. The growing initiative of hospitals to provide latest procedures and services to public aids the growth of the Aortic Valve Replacement Industry.

Geography - Segment Analysis

In 2018, Europe region occupied 46% of the global Aortic Valve Replacement market in terms of revenue. According to a journal published by the European Heart Journal, Aortic stenosis is the most common primary valve disease leading to surgery or catheter intervention in Europe and North America, with a growing prevalence due to the ageing population.

Drivers – Aortic Valve Replacement Market

• Rising Prevalence of Cardiovascular Diseases

According to WHO, Cardiovascular diseases were responsible for an estimated 17.8Mn deaths in 2017. Strokes, heart attacks, congestive heart failure and other conditions are often an outcome of a blocked valve. Aortic valve replacement using tissue valves are procedures done to replace the damaged valve with another prosthetic valve.

• Favorable reimbursement scenario

The expenditure of people on healthcare and the prevalence of various kind of diseases are increasing. This leads public to have very little disposable income. Thus, government policies have been put into place to aid public by covering a portion of their healthcare expenses. For example Medicare and Medicaid are initiatives by the US government to help medical costs for some people with limited income and resources.

Challenges – Aortic Valve Replacement Market

Stringent Regulatory Norms

Stringent government regulations for approval of transcatheter aortic valve, the risk associated with the procedure hinders the growth of the market. Certain products have failed the tests due to incompetent results after clinical trials.

Aortic Valve Replacement Industry Outlook

Product Launches along is the key strategy of the players in the Aortic Valve Replacement market. In 2018, Aortic Valve replacement market share is consolidated by the key players present in the aortic valve replacement industry. cThe Aortic Valve Replacement top 10 companies include Venus Medtech Inc, Medtronic Plc, LivaNova PLC, LifeNet Health, Jenavalve Technology Inc, Edwards Lifesciences Corporation, CryoLife Inc, Bracco Spa, Boston Scientific Corp and Abbott Laboratories.

Aortic Valve Replacement Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Aortic Valve Replacement industry. The assessment includes the forecast, an overview of the competitive structure, the aortic valve replacement market share of the competitors, aortic valve replacement market size, as well as the market trends, market demands, market drivers, market challenges, and product/service analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include product, procedure, end-user and geography. 

Key Market Players:

The Top 5 companies in the Aortic Valve Replacement Market      are:
1 Abbott Laboratories
2 Boston Scientific
3 Medtronic Plc
4. Edwards Lifesciences Corp.
5 LivaNova Plc.